Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
PETROCHINA
00857
5
SINOPEC CORP
00386
CN Stock MarketDetailed Quotes
Joincare Pharmaceutical Group Industry (600380)
- 10.76
- -0.08-0.74%
Market Closed May 7 15:00 CST
19.68BMarket Cap14.97P/E (TTM)
10.92High10.75Low134.32KlotVolume10.88Open10.84Prev Close144.95MTurnover0.73%Turnover Ratio14.74P/E (Static)1.83BShares14.2152wk High1.26P/B19.68BFloat Cap10.3052wk Low11.92Limit Up1.83BShs Float23.64Historical High9.76Limit Down1.57%Range %0.63Historical Low0.20Dividend TTM10.79Avg Price82.87KlotAsk1.86%Div Yield TTM100Lot Size47.80KlotBid
Joincare Pharmaceutical Group Industry (600380) Income Statement
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -8.99%3.72B | -2.58%15.22B | -3.54%11.48B | -4.08%7.9B | -5.77%4.09B | -6.17%15.62B | -5.95%11.9B | -5.56%8.23B | -4.81%4.34B | -2.90%16.65B |
| Operating revenue | -8.99%3.72B | -2.58%15.22B | -3.54%11.48B | -4.08%7.9B | -5.77%4.09B | -6.17%15.62B | -5.95%11.9B | -5.56%8.23B | -4.81%4.34B | -2.90%16.65B |
| Other operating revenue | ---- | -0.51%127.26M | ---- | 11.34%68.11M | ---- | 2.63%127.91M | ---- | -8.63%61.17M | ---- | -4.15%124.63M |
| Total operating cost | -8.60%2.74B | -0.79%11.89B | -3.92%8.76B | -5.36%5.91B | -9.20%2.99B | -8.67%11.99B | -8.71%9.12B | -8.83%6.25B | -7.50%3.3B | -4.80%13.12B |
| Operating cost | -12.10%1.37B | -1.95%5.71B | -3.16%4.25B | -1.19%2.99B | -1.90%1.56B | -7.47%5.83B | -9.15%4.39B | -7.71%3.02B | -7.29%1.59B | 0.74%6.3B |
| Operating tax surcharges | -2.20%47.43M | 2.08%194.36M | 3.77%142.76M | 5.85%99.5M | 3.82%48.5M | -6.30%190.41M | -8.46%137.57M | -8.48%94M | -14.46%46.72M | 1.73%203.21M |
| Operating expense | -5.68%896.56M | 5.72%4.15B | 2.78%3.03B | -3.81%2.02B | -13.40%950.57M | -11.53%3.92B | -13.91%2.95B | -12.61%2.1B | -10.07%1.1B | -10.43%4.43B |
| Administration expense | -8.46%202.19M | -4.51%870.49M | -6.18%664.9M | -5.20%421.89M | -14.94%220.89M | -2.03%911.6M | 4.22%708.73M | 2.34%445.02M | 24.10%259.69M | -6.25%930.48M |
| Financial expense | 83.42%-14.21M | -2.25%-308.78M | -147.93%-262.73M | -79.18%-221.7M | -16.36%-85.69M | 25.41%-301.98M | 66.30%-105.97M | -0.93%-123.73M | -364.30%-73.64M | -14.87%-404.84M |
| -Interest expense (Financial expense) | -32.32%15.5M | -29.38%87.05M | -29.64%66.82M | -36.89%45.73M | -32.12%22.9M | -15.99%123.26M | -10.76%94.97M | 3.42%72.46M | 2.11%33.73M | 5.55%146.73M |
| -Interest Income (Financial expense) | 41.51%-64.9M | -12.47%-469.34M | -48.12%-364.35M | -31.28%-246.07M | -8.00%-110.97M | 21.60%-417.3M | 34.09%-245.99M | -37.88%-187.44M | -50.62%-102.75M | -34.59%-532.25M |
| Research and development | -22.19%233.7M | -11.31%1.27B | -10.17%931.02M | -14.49%611.15M | -20.35%300.36M | -13.62%1.44B | -14.46%1.04B | -6.59%714.73M | -1.07%377.1M | -4.61%1.66B |
| Credit Impairment Loss | 108.06%659.06K | 71.85%-2.04M | -1,163.69%-10.07M | -89.30%-7.33M | -24.25%-8.18M | 56.89%-7.26M | 95.51%-797.21K | 82.56%-3.87M | 57.41%-6.58M | -308.52%-16.85M |
| Asset Impairment Loss | 88.65%-721.49K | 58.80%-120.79M | 81.63%-20.89M | 81.97%-14.81M | -55.89%-6.36M | 6.15%-293.14M | -4.84%-113.69M | -172.39%-82.19M | -321.87%-4.08M | -119.01%-312.37M |
| Other net revenue | -2.35%54.46M | 930.41%141.13M | 184.28%157.02M | 132,185.73%95.94M | 19.07%55.77M | -4.46%-16.99M | 49.64%55.24M | -99.92%72.53K | -11.15%46.84M | -113.32%-16.27M |
| Fair value change income | -1,132.95%-17.66M | 211.42%19.49M | 158.07%3.33M | 65.78%-6.7M | 47.23%1.71M | 31.17%-17.5M | 87.53%-5.74M | 50.21%-19.58M | 104.23%1.16M | 66.67%-25.42M |
| Invest income | 203.87%49.03M | 11.06%71.49M | 25.51%64.83M | 11.87%39.54M | -20.99%16.14M | -19.00%64.37M | -11.81%51.65M | -37.83%35.35M | -48.47%20.42M | 41.99%79.47M |
| -Including: Investment income associates | 92.59%38.16M | 123.83%60.61M | 72.74%59.37M | 65.87%39.48M | 8.90%19.82M | -62.80%27.08M | -40.61%34.37M | -46.91%23.8M | 58.64%18.2M | 3.14%72.79M |
| Asset deal income | 25.63%-64.05K | -93.43%2.97M | 14.81%-315.53K | -95.87%-149.72K | -128.09%-86.13K | 26,740.64%45.26M | -84.76%-370.4K | 77.67%-76.44K | --306.57K | 75.91%-169.9K |
| Other revenue | -55.83%23.21M | -11.12%170M | -3.26%120.14M | 21.24%85.4M | 47.56%52.55M | -26.17%191.27M | -17.61%124.18M | -44.06%70.44M | -34.28%35.61M | -10.63%259.06M |
| Operating profit | -9.69%1.04B | -4.16%3.47B | 1.36%2.87B | 4.76%2.08B | 5.64%1.15B | 3.13%3.62B | 5.06%2.83B | 1.48%1.99B | 4.00%1.09B | 0.77%3.51B |
| Add:Non operating Income | -15.35%993.67K | 25.50%9.77M | -8.10%6.36M | 5.12%5.19M | -37.55%1.17M | -2.45%7.78M | 9.80%6.92M | 181.15%4.94M | 114.44%1.88M | -3.03%7.98M |
| Less:Non operating expense | 119.05%4.53M | 122.42%109.39M | 22.55%24.5M | 41.96%13.96M | -64.85%2.07M | 0.39%49.18M | -15.89%19.99M | 33.38%9.83M | 58.92%5.88M | 52.81%48.99M |
| Total profit | -9.93%1.04B | -5.83%3.37B | 1.19%2.85B | 4.58%2.07B | 5.95%1.15B | 3.15%3.57B | 5.25%2.82B | 1.53%1.98B | 3.90%1.09B | 0.27%3.47B |
| Less:Income tax cost | -19.27%153.39M | -15.34%501.28M | 5.85%408.17M | 8.12%309.03M | 17.70%189.99M | -3.64%592.14M | -11.11%385.62M | -11.97%285.81M | -3.46%161.42M | 9.39%614.54M |
| Net profit | -8.08%883.45M | -3.95%2.87B | 0.45%2.44B | 3.98%1.76B | 3.89%961.12M | 4.62%2.98B | 8.42%2.43B | 4.22%1.7B | 5.30%925.1M | -1.50%2.85B |
| Net profit from continuing operation | -8.08%883.45M | -3.95%2.87B | 0.45%2.44B | 3.98%1.76B | 3.89%961.12M | 4.62%2.98B | 8.42%2.43B | 4.22%1.7B | 5.30%925.1M | -1.50%2.85B |
| Less:Minority Profit | -10.82%468.48M | -4.18%1.53B | 2.36%1.35B | 6.41%978.77M | 8.25%525.34M | 13.35%1.6B | 13.86%1.32B | 13.26%919.79M | 16.72%485.3M | 1.20%1.41B |
| Net profit of parent company owners | -4.78%414.97M | -3.68%1.34B | -1.83%1.09B | 1.10%784.94M | -0.91%435.79M | -3.90%1.39B | 2.58%1.11B | -4.78%776.42M | -4.96%439.8M | -3.99%1.44B |
| Earning per share | ||||||||||
| Basic earning per share | 0.00%0.23 | -1.35%0.73 | 1.69%0.6 | 2.38%0.43 | -4.17%0.23 | -2.63%0.74 | 3.84%0.59 | -1.50%0.42 | -0.17%0.24 | -4.21%0.76 |
| Diluted earning per share | 0.00%0.23 | -1.35%0.73 | 1.69%0.6 | 2.38%0.43 | -4.17%0.23 | -2.63%0.74 | 4.19%0.59 | -1.20%0.42 | 0.08%0.24 | -4.06%0.76 |
| Other composite income | -294.29%-70.53M | -1,842.79%-166.83M | 8.95%-78.93M | -175.09%-80.04M | 20.66%-17.89M | 76.05%-8.59M | -282.58%-86.69M | -196.73%-29.1M | 73.05%-22.55M | -148.06%-35.86M |
| Other composite income of parent company owners | -369.31%-48.22M | -875.80%-99.08M | 18.79%-48.22M | -104.96%-48.52M | -2.42%-10.28M | 31.76%-10.15M | -6,002.98%-59.37M | -175.93%-23.68M | 78.78%-10.03M | -2,078.08%-14.88M |
| Other composite income of minority owners | -193.03%-22.31M | -4,426.36%-67.76M | -12.45%-30.72M | -481.33%-31.52M | 39.16%-7.61M | 107.46%1.57M | -15.44%-27.32M | -392.17%-5.42M | 65.61%-12.51M | -127.87%-20.98M |
| Total composite income | -13.82%812.92M | -9.28%2.7B | 0.79%2.37B | 0.99%1.68B | 4.51%943.23M | 5.65%2.97B | 5.62%2.35B | 0.57%1.67B | 13.55%902.55M | -5.18%2.82B |
| Total composite income of parent company owners | -13.81%366.75M | -10.17%1.24B | -0.87%1.04B | -2.17%736.42M | -0.99%425.51M | -3.61%1.38B | -2.99%1.05B | -11.09%752.75M | 3.44%429.77M | -4.94%1.43B |
| Total composite income of minority owners | -13.82%446.17M | -8.51%1.46B | 2.15%1.32B | 3.60%947.25M | 9.50%517.72M | 15.17%1.6B | 13.83%1.29B | 12.74%914.37M | 24.62%472.79M | -5.42%1.39B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | PwC China (Special General Partnership) | -- | -- | -- | PwC China (Special General Partnership) | -- | -- | -- | PwC China (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm